Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is DexCom, Inc. (DXCM) A Good Stock To Buy?

Insider Monkey finished processing more than 700 13F filings made by hedge funds and prominent investors. These filings show these funds’ portfolio positions as of September 30. In this article we are going to take a look at smart money sentiment towards DexCom, Inc. (NASDAQ:DXCM).

DexCom, Inc. (NASDAQ:DXCM) shareholders have witnessed an increase in hedge fund sentiment recently. DXCM was in 26 hedge funds’ portfolios at the end of the third quarter of 2016. There were 25 hedge funds in our database with DXCM positions at the end of the previous quarter. At the end of this article we will also compare DXCM to other stocks including New Oriental Education & Tech Grp (ADR) (NYSE:EDU), Hyatt Hotels Corporation (NYSE:H), and FactSet Research Systems Inc. (NYSE:FDS) to get a better sense of its popularity.

Follow Dexcom Inc (NASDAQ:DXCM)
Trade (NASDAQ:DXCM) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

medicine, diabetes, glycemia, health care,patient, insulin-deficient, middle, app, measurement, male, disease, hypoglycemia, level, technology, medicine, mobile, checking, body, home, smartphone, hyperglycemia, stripe, part, health, indoors, man, glucometer, healthcare, test, human, diabetic, aged, medical, unhealthy, concept, gadget, ill, diabetes, sick, glucose, care, problem, person, cell, sugar, control, application, phone, blood, hand, insulin

Syda Productions/

What does the smart money think about DexCom, Inc. (NASDAQ:DXCM)?

At the end of the third quarter, a total of 26 of the hedge funds tracked by Insider Monkey were bullish on this stock, a rise of 4% from the second quarter of 2016, though hedge fund ownership remains well beneath its level of 9 months earlier. With hedgies’ sentiment swirling, there exists a select group of key hedge fund managers who were upping their holdings significantly (or already accumulated large positions).


Of the funds tracked by Insider Monkey, Columbus Circle Investors, managed by Principal Global Investors, holds the number one position in DexCom, Inc. (NASDAQ:DXCM). Columbus Circle Investors has a $124.5 million position in the stock, comprising 1.3% of its 13F portfolio. On Columbus Circle Investors’ heels is Bridger Management, managed by Roberto Mignone, which holds a $47.2 million position; 3.2% of its 13F portfolio is allocated to the company. Some other professional money managers with similar optimism comprise Jerome Pfund and Michael Sjostrom’s Sectoral Asset Management, Steve Cohen’s Point72 Asset Management, and Joseph Edelman’s Perceptive Advisors.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.